Last $35.32 USD
Change Today +0.44 / 1.26%
Volume 184.9K
INSY On Other Exchanges
Symbol
Exchange
NASDAQ GM
Frankfurt
As of 8:10 PM 08/29/14 All times are local (Market data is delayed by at least 15 minutes).

Executive Profile*

Daniel Douglas Von Hoff M.D., F.A.C.P.

Senior Vice President of Medical Affairs, Lorus Therapeutics Inc.
AgeTotal Calculated CompensationThis person is connected to 598 board members in 60 different organizations across 84 different industries.

See Board Relationships
66--

Background*

Dr. Daniel Douglas Von Hoff, also known as Dan, M.D., F.A.C.P., serves as a Senior Advisor of Clinical Development at Tolero Pharmaceuticals, Inc. and also served as its Senior Vice President of Clinical Development. Dr. Von Hoff has been Senior Vice President of Medical Affairs at Lorus Therapeutics Inc., since October 28, 2013. He co-founded Cylene Pharmaceuticals, Inc. in 1998 and serves as its Senior Vice President of Medical Affairs. He serves as the Chief Scientific ...

Read Full Background

Corporate Headquarters*

444 South Ellis Street
Chandler, Arizona 85224

United States

Phone: 602-910-2617
Fax: 602-910-2627

Board Members Memberships*

Co-Founder, Senior Vice President of Medical Affairs, Director and Member of Scientific Advisory Board
Former Member of Scientific Advisory Board
Co-Founder
Co-Founder, Chief Medical Officer and Director
Chief Scientific Officer and Director
1994-N/A
Former Director
2000-2012
Former Director, Member of Audit Committee, Member of Compensation Committee and Member of Nominating & Corporate Governance Committee

Education*

BS
Carroll College (Montana)
MD
Columbia University College of Physicians & Surgeons in New York

Other Affiliations*

Annual Compensation*

There is no Annual Compensation data available.

Stock Options*

There is no Stock Options data available.

Total Compensation*

There is no Total Compensation data available.
*Data is at least as current as the most recent Definitive Proxy.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
INSY:US $35.32 USD +0.44

COMPETITOR COMPENSATION

There is no Competitor Compensation data available.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact INSYS THERAPEUTICS INC, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.